Companion Diagnostic
Companion diagnostics, which are developed based on validated biomarkers and used in conjunction with drugs, enable personalized medicine by predicting response, adverse effects and dosage for a particular patient. Companion diagnostics has well hit the frontline of drug discovery and development in the past few years. Major pharmaceutical companies have adopted the concept of using companion diagnostics to target safer and more effective pharmaceutics.
In Dx assays, we provide service package for developing and validating companion diagnostic products with the focus on genetic markers. We offer the flexibility on choices of platform and chemistry based on client specifications. The pipeline of companion diagnostic would be similar to the assay development process which includes both Design and Feasibility Studies, and Design Transfer.
In Dx assays, we provide service package for developing and validating companion diagnostic products with the focus on genetic markers. We offer the flexibility on choices of platform and chemistry based on client specifications. The pipeline of companion diagnostic would be similar to the assay development process which includes both Design and Feasibility Studies, and Design Transfer.